Related Experiment Video
Updated: Apr 19, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
MTA1 downregulation inhibits malignant potential in a small cell lung cancer cell line
Hongsheng Xue1, Haijuan Wang1, Jian Liu1
1State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 100021, P.R. China.
Abstract:
As a component of the nuclear remodeling and deacetylation complex (NuRD complex), metastasis-associated gene 1 (MTA1) has been reported to play a key role in cancer malignancy. However, whether MTA1 functions in small cell lung cancer (SCLC) malignant behavior and whether it is feasible to be used as a therapeutic target have not been evaluated. The present study aimed to investigate the effects of MTA1 downregulation on SCLC malignancy. First we demonstrated the overexpression of MTA1 in SCLC specimens. After knocking down the MTA1 level by specific siRNA sequence, the biological consequences on proliferation, migration, invasion and apoptosis were evaluated. The results showed that MTA1 silencing had potent suppressive effects on SCLC proliferation, migration and invasion. Apoptosis but not cell cycle arrest was induced in the MTA1-silenced SCLC cells. In summary, MTA1 plays a critical role in regulating the malignant behaviors of SCLC. Depleting MTA1 level may be an effective strategy by which to suppress SCLC growth and metastasis in future biotherapeutic attempts.
Insights
Metastasis-associated gene 1 (MTA1) drives small cell lung cancer (SCLC) malignancy. Downregulating MTA1 effectively suppresses SCLC proliferation, migration, invasion, and induces apoptosis, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis-associated gene 1 (MTA1) is a component of the NuRD complex and implicated in cancer malignancy.
- Its role in small cell lung cancer (SCLC) malignant behavior and therapeutic potential remain largely unevaluated.
Purpose of the Study:
- To investigate the effects of MTA1 downregulation on SCLC malignancy.
- To assess MTA1 as a potential therapeutic target in SCLC.
Main Methods:
- Demonstrated MTA1 overexpression in SCLC specimens.
- Utilized small interfering RNA (siRNA) to knockdown MTA1 levels.
- Evaluated biological consequences including proliferation, migration, invasion, and apoptosis.
Main Results:
- MTA1 was found to be overexpressed in SCLC specimens.
- MTA1 silencing significantly suppressed SCLC proliferation, migration, and invasion.
- MTA1 depletion induced apoptosis in SCLC cells, without causing cell cycle arrest.
Conclusions:
- MTA1 plays a critical role in regulating the malignant behaviors of SCLC.
- Depleting MTA1 may represent an effective biotherapeutic strategy to inhibit SCLC growth and metastasis.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

